Search Results 1081-1090 of 21726 for Inhibition
... inhibitor therapy. A Study to Evaluate 68Ga- PSMA-Dual Contrast PET/MRI and ... inhibitors. A Phase II Study of ABC294640 as Second-Line Monotherapy in ...
Currently taking medication known to be strong inhibitors of CYP3A4. ... Currently taking medication known to be potent inhibitors of P-gp. Acute IPF ...
For patients on phosphodiesterase type-5 inhibitors ... Treatment with strong cytochrome P450 (CYP) 3A4 inducers or inhibitors within 4 weeks prior to Visit 2 ...
... inhibitor (such as methylene blue injection, Eldepryl®, Marplan®, Nardil®, Parnate®), medicine to treat migraine headaches (such as tramadol, Ultram®), or ...
... inhibitor therapy; Patients undergoing clinically indicated upper endoscopy for indications other than dysphagia or GERD with normal appearing esophageal ...
AXL Inhibition Improves the Antitumor Activity of Chimeric Antigen Receptor T Cells. Cancer Immunol Res. 2023 Sep 01; 11(9):1222-1236. View PubMed; Yoon HH ...
Use of chronic medications (statins, anti-inflammatory drugs, angiotensin II receptor blockers (ARBs) and/or angiotensin-converting enzyme (ACE) inhibitors).
Patients on use of angiotensin receptor inhibitors. Patients with pulmonary fibrosis. Patients with bronchiectasis. Patients with lung cancer. Patients in ...
So, sglt2 inhibitors used initially only for patients with diabetes, and these days, introducing the guidelines for the treatment of heart failure. And the.
... inhibitors in high grade IDH mutant gliomas. JCI Insight. 2025 Oct 9 ... IDH inhibition in gliomas: from preclinical models to clinical trials. Nat ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.